198 related articles for article (PubMed ID: 37517044)
1. Phenolic compounds as potential adenosine deaminase inhibitors: molecular docking and dynamics simulation coupled with MM-GBSA calculations.
Uba AI; Paradis NJ; Wu C; Zengin G
Amino Acids; 2023 Dec; 55(12):1729-1743. PubMed ID: 37517044
[TBL] [Abstract][Full Text] [Related]
2. Understanding the mode of inhibition and molecular interaction of taxifolin with human adenosine deaminase.
Rawat RS; Kumar S
J Biomol Struct Dyn; 2023 Feb; 41(2):377-385. PubMed ID: 34851227
[TBL] [Abstract][Full Text] [Related]
3. Computational and experimental validation of morin as adenosine deaminase inhibitor.
Arun KG; Sharanya CS; Sadasivan C
J Recept Signal Transduct Res; 2018 Jun; 38(3):240-245. PubMed ID: 29843562
[TBL] [Abstract][Full Text] [Related]
4. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
5. Computational investigation of phytochemicals from
Omoboyowa DA; Singh G; Fatoki JO; Oyeneyin OE
J Biomol Struct Dyn; 2023; 41(12):5568-5582. PubMed ID: 35773777
[TBL] [Abstract][Full Text] [Related]
6. Probing inhibition mechanisms of adenosine deaminase by using molecular dynamics simulations.
Tian X; Liu Y; Zhu J; Yu Z; Han J; Wang Y; Han W
PLoS One; 2018; 13(11):e0207234. PubMed ID: 30444912
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.
Kutryb-Zajac B; Mierzejewska P; Slominska EM; Smolenski RT
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053898
[TBL] [Abstract][Full Text] [Related]
8. Repurposing of Streptomyces antibiotics as adenosine deaminase inhibitors by pharmacophore modeling, docking, molecular dynamics, and
Arun KG; Sharanya CS; Abhithaj J; Sadasivan C
J Recept Signal Transduct Res; 2020 Feb; 40(1):77-88. PubMed ID: 31971048
[TBL] [Abstract][Full Text] [Related]
9. Potential Effect of Baobab's Polyphenols as Antihyperlipidemic Agents: In Silico Study.
Alameen AA; Alothman MR; Al Wahibi MS; Abdullah EM; Ali R; Abdalla M; Fattiny SZA; Elsayim R
Molecules; 2023 Aug; 28(16):. PubMed ID: 37630364
[No Abstract] [Full Text] [Related]
10. In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds.
Broni E; Ashley C; Velazquez M; Khan S; Striegel A; Sakyi PO; Peracha S; Bebla K; Sodhi M; Kwofie SK; Ademokunwa A; Miller WA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628792
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and computational insights of adenosine deaminase inhibition by Epigallocatechin gallate.
K G A; C S S; J A; C S
Comput Biol Chem; 2019 Dec; 83():107111. PubMed ID: 31445420
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
[TBL] [Abstract][Full Text] [Related]
13. A new mixed inhibitor of adenosine deaminase produced by endophytic Cochliobolus sp. from medicinal plant seeds.
Zhang XG; Sun QY; Tang P; Ma GY; Guo GJ; Guo SJ; Ma XD
Folia Microbiol (Praha); 2020 Apr; 65(2):293-302. PubMed ID: 31273645
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of Plasmodium falciparum adenosine deaminase reveals a novel binding pocket for inosine.
Jaruwat A; Riangrungroj P; Ubonprasert S; Sae-Ueng U; Kuaprasert B; Yuthavong Y; Leartsakulpanich U; Chitnumsub P
Arch Biochem Biophys; 2019 May; 667():6-13. PubMed ID: 31002765
[TBL] [Abstract][Full Text] [Related]
15. Exploring binding mode assessment of novel kaempferol, resveratrol, and quercetin derivatives with PPAR-α as potent drug candidates against cancer.
Ballav S; Lokhande KB; Yadav RS; Ghosh P; Swamy KV; Basu S
Mol Divers; 2023 Dec; 27(6):2867-2885. PubMed ID: 36544031
[TBL] [Abstract][Full Text] [Related]
16. Development of a Simple Assay Method for Adenosine Deaminase via Enzymatic Formation of an Inosine-Tb
Lee S; Park H; Ki Y; Lee H; Han MS
Sensors (Basel); 2019 Jun; 19(12):. PubMed ID: 31216643
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potent DNMT1 inhibitors against sickle cell disease using structural-based virtual screening, MM-GBSA and molecular dynamics simulation-based approaches.
Ala C; Joshi RP; Gupta P; Ramalingam S; Sankaranarayanan M
J Biomol Struct Dyn; 2024; 42(1):261-273. PubMed ID: 37061929
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential ATP-competitive cyclin-dependent kinase 1 inhibitors: De novo drug generation, molecular docking, and molecular dynamics simulation.
He F; Wang X; Wu Q; Liu S; Cao Y; Guo X; Yin S; Yin N; Li B; Fang M
Comput Biol Med; 2023 Mar; 155():106645. PubMed ID: 36774892
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antibody response in the presence of partial adenosine deaminase inhibition.
Hoffman EA; Kopp WC; Moat AG
Proc Soc Exp Biol Med; 1990 May; 194(1):36-42. PubMed ID: 2139230
[TBL] [Abstract][Full Text] [Related]
20. Target-based virtual screening, computational multiscoring docking and molecular dynamics simulation of small molecules as promising drug candidate affecting kinesin-like protein KIFC1.
Khan MKA; Ahmad S; Rabbani G; Shahab U; Khan MS
Cell Biochem Funct; 2022 Jul; 40(5):451-472. PubMed ID: 35758564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
